Q3 2024 13F Holders as of 30 Sep 2024
-
Type / Class
-
Equity / Ordinary Shares, par value EUR0.01 per share
-
Shares outstanding
-
83,110,104
-
Total 13F shares
-
27,383,884
-
Share change
-
-720,926
-
Total reported value
-
$312,847,988
-
Price per share
-
$11.52
-
Number of holders
-
40
-
Value change
-
-$8,252,199
-
Number of buys
-
20
-
Number of sells
-
13
Institutional Holders of Abivax S.A. - Ordinary Shares, par value EUR0.01 per share (ABVX) as of Q3 2024
As of 30 Sep 2024,
Abivax S.A. - Ordinary Shares, par value EUR0.01 per share (ABVX) was held by
40 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
27,383,884 shares.
The largest 10 holders included
TCG Crossover Management, LLC, Deep Track Capital, LP, Cormorant Asset Management, LP, GREAT POINT PARTNERS LLC, Blackstone Inc., VR Adviser, LLC, FRANKLIN RESOURCES INC, COMMODORE CAPITAL LP, Nantahala Capital Management, LLC, and Samsara BioCapital, LLC.
This page lists
40
institutional shareholders reporting positions in this security
for the Q3 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.